Conference session considers what is needed for radioligand therapy in prostate cancer

Conference session considers what is needed for radioligand therapy in prostate cancer

The Health Policy Partnership held a session on multidisciplinary collaboration for health system readiness at the 13th European Multidisciplinary Congress on Urological Cancers.
Read More
Register for the virtual event: ‘Achieving readiness for radioligand therapy in the US’

Register for the virtual event: ‘Achieving readiness for radioligand therapy in the US’

On 3 November, The Health Policy Partnership and Avalere Health are holding an online event to examine the use of radioligand therapy in the US.
Read More
HPP to hold session on radioligand therapy at EMUC21

HPP to hold session on radioligand therapy at EMUC21

The Health Policy Partnership is hosting the session ‘Radioligand therapy: multidisciplinary collaboration for health system readiness’ at EMUC21 on 25 November.
Read More
Join HPP webinar on system readiness in cancer care

Join HPP webinar on system readiness in cancer care

To coincide with ESMO 2021, The Health Policy Partnership is holding a webinar to launch the policy brief 'Fostering system readiness in cancer care'.
Read More
Register for launch of the radioligand therapy readiness assessment for the UK

Register for launch of the radioligand therapy readiness assessment for the UK

Join the The Health Policy Partnership on 9 Sept for an online event to launch the UK application of the Radioligand Therapy Readiness Assessment Framework.
Read More
Launch of the Radioligand Therapy Readiness Assessment Framework

Launch of the Radioligand Therapy Readiness Assessment Framework

Join The Health Policy Partnership on Wednesday 9 June for a webinar and an in-depth discussion on health system readiness for radioligand therapy.
Read More